PBSL PBSLPBSL/GL/002, Version 03, Revision 02
PBSL/GL/002, Version 03, Revision 02 is the official PBSL identifier for “Guidelines for Application and Authorisation of Clinical Trials of Medicines, Vaccines, Medical Devices and Food Supplements in Sierra Leone”. PBSL/GL/002, Version 03, Revision 02 is the official identifier PBSL uses for this instrument.
- Instrument
- PBSL
- Full name
- PBSL/GL/002, Version 03, Revision 02
- Category
- Clinical Trials
- Source publication
- English
- Readable HTML
- 1 language version
- Published
- 15 May 2024
- Effective
- 17 May 2024
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Guidelines for Application and Authorisation of Clinical Trials of Medicines, Vaccines, Medical Devices and Food Supplements in Sierra Leone
Complete 120-page PBSL clinical-trial guideline, including its application requirements, oversight provisions and annexes. Its scope expressly includes medical devices alongside medicines, vaccines and food supplements. The authority lists the file in its 2025 collection; the document itself states the 2024 issue and effective dates.
PBSL/GL/002, Version 03, Revision 02 is the official identifier PBSL uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.